Page last updated: 2024-10-29

ipriflavone and Sjogren's Syndrome

ipriflavone has been researched along with Sjogren's Syndrome in 1 studies

ipriflavone : A member of the class of isoflavones that is isoflavone in which the hydrogen at position 7 is replaced by an isopropoxy group. A synthetic isoflavone, it was formerly used for the treatment of osteoporosis, although a randomised controlled study failed to show any benefit. It is still used to prevent osteoporosis in post-menopausal women.

Sjogren's Syndrome: Chronic inflammatory and autoimmune disease in which the salivary and lacrimal glands undergo progressive destruction by lymphocytes and plasma cells resulting in decreased production of saliva and tears. The primary form, often called sicca syndrome, involves both KERATOCONJUNCTIVITIS SICCA and XEROSTOMIA. The secondary form includes, in addition, the presence of a connective tissue disease, usually rheumatoid arthritis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Okada, M1
Suzuki, K1
Hidaka, T1
Shinohara, T1
Kataharada, K1
Matsumoto, M1
Takada, K1
Ohsuzu, F1

Other Studies

1 other study available for ipriflavone and Sjogren's Syndrome

ArticleYear
Rapid improvement of osteomalacia by treatment in a case with Sjögren's syndrome, rheumatoid arthritis and renal tubular acidosis type 1.
    Internal medicine (Tokyo, Japan), 2001, Volume: 40, Issue:8

    Topics: Acidosis, Renal Tubular; Adjuvants, Immunologic; Analgesics; Arthritis, Rheumatoid; Bone Density; Ca

2001